• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
Y0300370 人血白蛋白 human albumin Injection Biological Products Supplementary Application 2003-02-09 成都蓉生药业有限责任公司 Chengdu Rongsheng Pharmaceuticals Co Ltd Certificate Issued 2003-11-14 view
Y0300369 人血白蛋白 human albumin Injection Biological Products Supplementary Application 2003-02-09 成都蓉生药业有限责任公司 Chengdu Rongsheng Pharmaceuticals Co Ltd Certificate Issued 2003-11-14 view
Y0300368 人血白蛋白 human albumin Injection Biological Products Supplementary Application 2003-02-09 成都蓉生药业有限责任公司 Chengdu Rongsheng Pharmaceuticals Co Ltd Certificate Issued 2003-11-14 view
Y0200022 静脉注射用人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2003-01-10 成都蓉生药业有限责任公司 Chengdu Rongsheng Pharmaceuticals Co Ltd Certificate Issued 2003-04-15 view
X0408486 b型流感嗜血杆菌结合疫苗 haemophilus influenzae type b conjugate vaccine Injection Biological Products New Drug Application 2005-01-12 成都蓉生药业有限责任公司 Chengdu Rongsheng Pharmaceuticals Co Ltd Certificate Issued 2006-02-10 view
X0301743 23价肺炎球菌多糖疫苗 23-valent pneumococcal polysaccharide vaccine Lyophilized Biological Products New Drug Application 2004-02-16 成都蓉生药业有限责任公司 Chengdu Rongsheng Pharmaceuticals Co Ltd Certificate Issued 2005-01-21 view
X0301742 冻干水痘减毒活疫苗 Lyophilized Biological Products New Drug Application 2004-01-12 成都蓉生药业有限责任公司 Chengdu Rongsheng Pharmaceuticals Co Ltd Certificate Issued 2004-12-24 view
CYSB2500020 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2025-01-17 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2500019 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2025-01-17 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2500018 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2025-01-17 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400309 狂犬病人免疫球蛋白 human rabies immunoglobulin Injection Biological Products Supplementary Application 2024-12-03 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400279 人纤维蛋白原 Human fibrinogen Lyophilized Biological Products Supplementary Application 2024-10-23 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400160 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-06-21 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400114 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2024-05-15 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400087 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2024-04-09 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2300152 破伤风人免疫球蛋白 human tetanus immunoglobulin Injection Biological Products Supplementary Application 2023-08-19 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2300113 人纤维蛋白原 Human fibrinogen Lyophilized Biological Products Supplementary Application 2023-06-13 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2200109 静注人免疫球蛋白(pH4) human immunoglobulin(PH4) Injection Biological Products Supplementary Application 2022-04-29 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2200078 人纤维蛋白原 Human fibrinogen Lyophilized Biological Products Supplementary Application 2022-03-16 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2200014 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-01-14 Chengdu Rongsheng Pharmaceuticals Co Ltd view